Abstract
Synthetic biology has shown that the metabolic behavior of mammalian cells can be altered by genetic devices such as epigenetic and hysteretic switches1,2, timers and oscillators3,4, biocomputers5, hormone systems6 and heterologous metabolic shunts7. To explore the potential of such devices for therapeutic strategies, we designed a synthetic mammalian circuit to maintain uric acid homeostasis in the bloodstream, disturbance of which is associated with tumor lysis syndrome and gout8,9. This synthetic device consists of a modified Deinococcus radiodurans-derived protein that senses uric acids levels and triggers dose-dependent derepression of a secretion-engineered Aspergillus flavus urate oxidase that eliminates uric acid. In urate oxidase–deficient mice, which develop acute hyperuricemia, the synthetic circuit decreased blood urate concentration to stable sub-pathologic levels in a dose-dependent manner and reduced uric acid crystal deposits in the kidney. Synthetic gene-network devices providing self-sufficient control of pathologic metabolites represent molecular prostheses, which may foster advances in future gene- and cell-based therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kramer, B.P. & Fussenegger, M. Hysteresis in a synthetic mammalian gene network. Proc. Natl. Acad. Sci. USA 102, 9517–9522 (2005).
Kramer, B.P. et al. An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol. 22, 867–870 (2004).
Fussenegger, M. Synthetic biology: Synchronized bacterial clocks. Nature 463, 301–302 (2010).
Tigges, M., Marquez-Lago, T.T., Stelling, J. & Fussenegger, M. A tunable synthetic mammalian oscillator. Nature 457, 309–312 (2009).
Rinaudo, K. et al. A universal RNAi-based logic evaluator that operates in mammalian cells. Nat. Biotechnol. 25, 795–801 (2007).
Weber, W., Daoud-El Baba, M. & Fussenegger, M. Synthetic ecosystems based on airborne inter- and intrakingdom communication. Proc. Natl. Acad. Sci. USA 104, 10435–10440 (2007).
Dean, J.T. et al. Resistance to diet-induced obesity in mice with synthetic glyoxylate shunt. Cell Metab. 9, 525–536 (2009).
Cairo, M.S. & Bishop, M. Tumour lysis syndrome: new therapeutic strategies and classification. Br. J. Haematol. 127, 3–11 (2004).
Terkeltaub, R.A. Clinical practice. Gout. N. Engl. J. Med. 349, 1647–1655 (2003).
Liebman, S.E., Taylor, J.G. & Bushinsky, D.A. Uric acid nephrolithiasis. Curr. Rheumatol. Rep. 9, 251–257 (2007).
Terkeltaub, R., Bushinsky, D.A. & Becker, M.A. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res. Ther. 8, S4 (2006).
Daly, M.J. A new perspective on radiation resistance based on Deinococcus radiodurans. Nat. Rev. Microbiol. 7, 237–245 (2009).
Wilkinson, S.P. & Grove, A. HucR, a novel uric acid-responsive member of the MarR family of transcriptional regulators from Deinococcus radiodurans. J. Biol. Chem. 279, 51442–51450 (2004).
Wilkinson, S.P. & Grove, A. Negative cooperativity of uric acid binding to the transcriptional regulator HucR from Deinococcus radiodurans. J. Mol. Biol. 350, 617–630 (2005).
Bellefroid, E.J., Poncelet, D.A., Lecocq, P.J., Revelant, O. & Martial, J.A. The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc. Natl. Acad. Sci. USA 88, 3608–3612 (1991).
Deans, T.L., Cantor, C.R. & Collins, J.J. A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 130, 363–372 (2007).
Oda, M., Satta, Y., Takenaka, O. & Takahata, N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol. Biol. Evol. 19, 640–653 (2002).
Enomoto, A. et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447–452 (2002).
Wu, X. et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc. Natl. Acad. Sci. USA 91, 742–746 (1994).
Legoux, R. et al. Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J. Biol. Chem. 267, 8565–8570 (1992).
Fluri, D.A., Kemmer, C., Daoud-El Baba, M. & Fussenegger, M. A novel system for trigger-controlled drug release from polymer capsules. J. Control. Release 131, 211–219 (2008).
Pacher, P., Beckman, J.S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315–424 (2007).
Whiteman, M. & Halliwell, B. Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic. Res. 25, 275–283 (1996).
Ames, B.N., Cathcart, R., Schwiers, E. & Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 78, 6858–6862 (1981).
Kutzing, M.K. & Firestein, B.L. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 324, 1–7 (2008).
Schwarzschild, M.A. et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch. Neurol. 65, 716–723 (2008).
Schumacher, H.R. Jr., Becker, M.A., Lloyd, E., MacDonald, P.A. & Lademacher, C. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology (Oxford) 48, 188–194 (2009).
Acknowledgements
We thank W. Weber (Albert-Ludwigs-Universität Freiburg, Germany) for conceptual input and for providing pBluescript-mHucR, M. Gilet for skillful assistance with the animal study and Marcia Schoenberg for critical comments on the manuscript. This work was supported by the Swiss National Science Foundation (grant no. 31003A-126022) and in part by the EC Framework 7 (Persist).
Author information
Authors and Affiliations
Contributions
C.K., J.S. and M.F. designed the project, analyzed results and wrote the manuscript. C.K., M.G., M.D.-E.B. and V.D. performed the experimental work. J.S. designed the mathematical model and performed simulations.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1–13 and Supplementary Tables 1–6 and Supplementary Results (PDF 407 kb)
Rights and permissions
About this article
Cite this article
Kemmer, C., Gitzinger, M., Daoud-El Baba, M. et al. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol 28, 355–360 (2010). https://doi.org/10.1038/nbt.1617
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1617
This article is cited by
-
Applications of synthetic biology in medical and pharmaceutical fields
Signal Transduction and Targeted Therapy (2023)
-
A cybergenetic framework for engineering intein-mediated integral feedback control systems
Nature Communications (2023)
-
Systems Medicine for Precise Targeting of Glioblastoma
Molecular Biotechnology (2023)
-
Genetic-code-expanded cell-based therapy for treating diabetes in mice
Nature Chemical Biology (2022)
-
Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells
Protein & Cell (2022)